top of page

Clara Ting

PharmD, BCCP

Rotations

Cardiology Clinic

Education

PharmD: Northeastern University

Residency Training

PGY1: Brigham and Women's Hospital
PGY2 Cardiology: Brigham and Women's Hospital

Practice Interests

Heart failure, cardiometabolic disease, anticoagulation, research

Clara Ting

Professional Affiliation

  • American College of Clinical Pharmacy

  • Cardiology Practice and Research Network: Vice-Chair, Membership Committee

Recent Publications

  • Alahmed AA, Lauffenburger JC, Vaduganathan M, Aldemerdash A, Ting C, Fatani N, Fanikos J, Buckley LF. Contemporary trends in the use of and expenditures on digoxin in the United States. Am J Cardiovasc Drugs. 2022 Sep;22(5):567-575.

  • Kelly J, Sylvester KW, Rimsans J, Bernier TD, Ting C, Connors JM. Heparin-induced thrombocytopenia in end-stage renal disease: Reliability of the PF4-heparin ELISA. Res Pract Thromb Haemost. 2021 Aug 4;5(5):e12573.

  • Chang LS, Lalmasi S, Hosomura N, Zhang H, Brown CJ, Lei VJ, Rubin A, Ting C, Tong K, Shubina M, Turchin A. Patient-provider discussions of bariatric surgery and subsequent weight changes and receipt of bariatric surgery. Obesity. 2021 Aug;29(8):1338-1346.

  • Bhatt AS, Varshney AS, Nekoui M, Moscone A, Cunningham JW, Jering KS, Patel PN, Sinnenberg LE, Bernier TD, Buckley LF, Cook B, Dempsey J, Kelly J, Knowles DM, Lupi K, Malloy R, Matta LS, Rhoten MN, Sharma K, Snyder CA, Ting C, McElrath EE, Amato MG, Alobaidly M, Ulbricht CE, Choudhry NK, Adler DS, Vaduganathan M. Virtual optimization of guideline-directed medical therapy in hospitalized patients with heart failure with reduced ejection fraction: the IMPLEMENT-HF Pilot Study. Eur J Heart Fail. 2021 Jul;23(7):1191-1201.

  • Ting C, Rhoten M, Dempsey J, Nichols H, Fanikos J, Ruff CT. Evaluation of direct oral anticoagulant prescribing in patients with moderate to severe renal impairment. Clin Appl Thromb Hemost. 2021 Jan-Dec;27:1076029620987900.

  • Buckley LF, Wohlford GF, Ting C, Alahmed A, Van Tassell BW, Abbate A, Devlin JW, Libby P. Role for anti-cytokine therapies in severe Coronavirus disease 2019. Crit Care Explor. 2020 Aug 10;2(8):e0178.

  • McLaughlin KE, Carabetta S, Hunt NF, Schuler BR, Ting C, Tran LK, Szumita PM, Anger KE. Safety of intravenous push lacosamide compared to intravenous piggyback at a tertiary academic medical center. Ann Pharmacother. 2021 Feb;55(2):181-186.

  • Ting C, Malloy R, Knowles DM. Assessment of sotalol and dofetilide dosing at a large academic medical center. J Cardiovasc Pharmacol Ther. 2020 Sep;25(5):438-443.

  • Buckley LF, Ting C, Fatani N, Fanikos J. Changes in nationwide Medicare and Medicaid expenditures on lipid-lowering therapies after PCSK9 inhibitor availability. J Clin Lipidol. 2020 May-Jun;14(3):315-321.e4.

  • Fatani N, Fanikos C, Ting C, Buckley LF, Fanikos J. Use of P2Y12 inhibitors among Medicaid beneficiaries between 2008 and 2018. J Thromb Thrombolysis. 2019 Nov;48(4):539-541.

  • Ting C, Fanikos C, Fatani N, Buckley LF, Fanikos J. Use of direct oral anticoagulants among patients with limited income and resources. J Am Coll Cardiol. 2019 Feb 5;73(4):526-528.

  • Ting C, Sylvester KW, Schurr JW. Time in the therapeutic range for assessing anticoagulation quality in patients treated with continuous unfractionated heparin. Clin Appl Thromb Hemost. 2018 Dec;24(9):178S-181S.

  • Sylvester KW, Ting C, Lewin A, Collins P, Fanikos J, Goldhaber SZ, Connors JM. Expanding anticoagulation management services to include direct oral anticoagulants. J Thromb Thrombolysis. 2018 Feb;45(2):274-280.

Academic and/or National Presentations

  • Feasibility of virtual optimization of guideline directed medical therapy in hospitalized patients with HFrEF during the Covid-19 Pandemic: the IMPLEMENT-HF pilot study. Presented virtually at the HFSA Late Breaking Clinical Trials Poster Session 2020.

  • Evaluation of 4T probability scores, heparin PF4 antibody, and serotonin release values in end stage renal disease patients in the assessment of heparin induced thrombocytopenia. Presented virtually at the ISTH 2020 Virtual Congress. 

  • Evaluation of direct oral anticoagulant prescribing in patients with moderate to severe renal impairment. Presented virtually at the MSHP Annual Meeting 2020 and ACC CV Pharmacist Virtual Poster Session 2020.

  • Increasing Medicaid expenditures on oral anticoagulants from 2010 to 2017. Presented at ASHP Midyear Clinical Meeting 2019, Las Vegas, NV. 

  • Hunt NF, Safety of intravenous push lacosamide compared to intravenous piggyback. Presented at ASHP Midyear Clinical Meeting 2018, Anaheim, CA.

  • Chang LS, Bariatric surgery counseling, changes in BMI, and receipt of bariatric surgery in patients with moderate to severe obesity. Presented at The Endocrine Society's Annual Meeting 2018, Chicago, IL. Abstract: Endocr Rev. 2018; 39(2):S. 

  • Time in the therapeutic range as a measure of anticoagulant control in patients treated with continuous unfractionated heparin. Presented at ASHP Midyear Clinical Meeting 2017, Orlando, FL.

  • A weighty issue: gender disparities in bariatric surgery counseling. Presented at The Obesity Society and American Society for Metabolic and Bariatric Surgery Annual Meeting 2017, Washington, D.C. Abstract: Surg Obes Relat Dis. 2017; 13(10):S66-S226.

Current Research

  • Clinical Impact of a Pharmacist-Led Medication Titration Clinic on Patients with Heart Failure with Reduced Ejection Fraction

bottom of page